First Affiliated Hospital of Chongqing Medical University Reports Findings in Co lon Cancer (Machine learning application identifies plasma markers for proteinur ia in metastatic colorectal cancer patients treated with Bevacizumab)

扫码查看

原文链接

NETL
NSTL

外文摘要：By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Oncology - Colon Cance r is the subject of a report. According to news reporting originating from Chong qing, People's Republic of China, by NewsRx correspondents, research stated, "Pr oteinuria is a common complication after the application of bevacizumab therapy in patients with metastatic colorectal cancer, and severe proteinuria can lead t o discontinuation of the drug. There is a lack of sophisticated means to predict bevacizumab-induced proteinuria, so the present study aims to predict bevacizum ab-induced proteinuria using peripheral venous blood samples."

外文关键词：

ChongqingPeople's Republic of ChinaA siaAntineoplastic Monoclonal AntibodiesAntineoplasticsBevacizumab TherapyBiomarkersBloodCancerColon CancerColorectal ResearchCyborgsDiagnost ics and ScreeningDrugs and TherapiesEmerging TechnologiesGastroenterologyHealth and MedicineHematologyImmunologic AgentsMachine LearningMonoclon al AntibodiesOncologyPharmaceuticalsPlasmaRisk and PreventionTyrosine Kinase InhibitorsVEGF - VEGFR InhibitorsVEGFR Inhibitors

出版年：

2024

Robotics & Machine Learning Daily News

ISSN：

年,卷(期)：2024.(Mar.11)